DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2013

Jul 11, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2013-07-09

Reporting Person: Janssen Robert (Chief Medical Officer and VP)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25481	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$1.36	2020-04-06	Common Stock (60000)		Direct
Option (Right to Buy)	$3.14	2021-01-05	Common Stock (22500)		Direct
Option (Right to Buy)	$3.68	2022-01-31	Common Stock (25000)		Direct
Option (Right to Buy)	$4.14	2022-10-30	Common Stock (150000)		Direct
Restricted Stock Unit	$4.22	2022-03-08	Common Stock (20000)		Direct

Footnotes

F1: This option grant vests in equal annual installments over four years on the anniversary of the grant date.

F2: This option grant shall vest over three (3) years with one third (1/3) of the Shares subject to the Option vesting twelve months after the Vesting Commencement Date, and one thirty-sixth (1/36) of the Shares subject to the Option vesting on the last day of each month thereafter.

F3: This option grant shall vest over four (4) years with one fourth (1/4) of the Shares subject to the Option vesting twelve months after the Vesting Commencement Date, and one forty-eighth (1/48) of the Shares subject to the Option vesting on the last day of each month thereafter.

F4: These restricted stock units shall vest upon achievement of certain performance conditions.